Literature DB >> 6642678

[Cefsulodin in the treatment of Pseudomonas meningitis].

O Brückner, H Collmann, M Trautmann.   

Abstract

Three patients with meningitis due to Pseudomonas aeruginosa (in one patient following a neurosurgical procedure and in two patients following severe head trauma with multiple skull bone fractures and liquorrhea) were treated with cefsulodin in combination with other antibiotics (aminoglycosides/acylureido penicillins). All of the patients were cured. Two patients received intraventricular administrations of aminoglycosides in addition to systemically applied antibiotics. After recurrence of pseudomonas meningitis in one patient in spite of the intraventricular application of an aminoglycoside, definite cure could only be obtained by additional intraventricular application of cefsulodin. The third patient was cured by systemic administration of cefsulodin and amikacin. The value of cefsulodin is discussed with reference to obtainable ventricular and lumbar CSF concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642678     DOI: 10.1007/BF01641258

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972.

Authors:  M Finland; M W Barnes
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

2.  Pseudomonas meningitis treated with azlocillin.

Authors:  C J Ellis; P H Walter
Journal:  Br Med J       Date:  1979-09-29

3.  Hospital-acquired bacterial meningitis in neurosurgical patients.

Authors:  F J Buckwold; R Hand; R R Hansebout
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

4.  Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.

Authors:  E J Perea; M C Nogales; J Aznar; E Martin; M C Iglesias
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa.

Authors:  S J Eykyn
Journal:  J Antimicrob Chemother       Date:  1982-05       Impact factor: 5.790

6.  Pseudomonas aeruginosa meningitis treated with an azlocillin combination.

Authors:  S Davidson; E O Yellin; I Shaked; E Rubinstein
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.

Authors:  W H Traub
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

Review 9.  Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis.

Authors:  J J Rahal; M S Simberkoff
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

Review 10.  Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; P M Shah; M Armengaud; M Barza; C E Cherubin
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

View more
  2 in total

1.  [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

Authors:  O Brückner; M Trautmann
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 2.  Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.

Authors:  Marlys LeBras; Ivy Chow; Vincent H Mabasa; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.